| Renal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived142 of 142show fewer |
|---|
| → investigated in trials for | Nivolumabmonoclonal_antibody 115 trials (49 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 115 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall_molecule 112 trials (9 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 112 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 106 trials (46 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 106 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall_molecule 67 trials (39 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall_molecule 58 trials (21 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal_antibody 55 trials (6 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 54 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal_antibody 53 trials (29 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall_molecule 52 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall_molecule 48 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall_molecule 30 trials (15 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 24 trials (19 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 22 trials (6 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 21 trials (9 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall_molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall_molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall_molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alpha-2a 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD-1 Monoclonal Antibody MEDI0680 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfacon-1other 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2aother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tandutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zenocutuzumab-zbcomonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |